Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID‐19
2020 ◽
Vol 45
(6)
◽
pp. 1515-1519
◽
2010 ◽
Vol 49
(22)
◽
pp. 2423-2432
◽
2011 ◽
Vol 12
(9)
◽
pp. 1481-1496
◽
1999 ◽
Vol 22
(1)
◽
pp. 91-128
◽
2008 ◽
Vol 14
(1)
◽
pp. 94-102
◽